# Filing Detail

Form ARS - Annual Report to Security Holders:
SEC Accession No. 0001193125-24-093409
Filing Date
2024-04-11
Accepted
2024-04-11 17:28:58
Documents
1
Period of Report
2023-12-31
Effectiveness Date
2024-04-11

Document Format Files

Seq | Description | Document | Type | Size
--- | --- | --- | --- | ---
1 | ARS | d710238dars.pdf | ARS | 857599
| Complete submission text file | 0001193125-24-093409.txt |  | 1182546

Mailing Address 400 PROFESSIONAL DR, SUITE 400 GAITHERSBURG MD 20879
Business Address 400 PROFESSIONAL DR, SUITE 400 GAITHERSBURG MD 20879 240-631-3200
Emergent BioSolutions Inc. (Filer) CIK: 0001367644 (see all company filings)

EIN.: 141902018 | State of Incorp.: DE | Fiscal Year End: 1231
Type: ARS | Act: 34 | File No.: 001-33137 | Film No.: 24839483
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)